Eyes and vision, Guidance

Applied filters

Care Setting (1)
- Paediatrics and neonates (1)
Guidance (59)
- In-use stability (1)
- Safety in Breastfeeding (53)
- Stability in dosette boxes (22)
- Stability outside the fridge (18)
- Supply (2)
Medicine (58)
- Acetazolamide (2)
- Acetylcysteine (1)
- Aciclovir (1)
- Adalimumab (1)
- Aflibercept (1)
- Atropine (1)
- Azelastine (1)
- Azithromycin (1)
- Betamethasone (1)
- Bevacizumab (1)
- Bimatoprost (1)
- Cefuroxime (1)
- Chloramphenicol (2)
- Ciclosporin (1)
- Ciprofloxacin (1)
- Cyclopentolate (1)
- Dexamethasone (1)
- Diclofenac sodium (1)
- Eculizumab (1)
- Fluocinolone acetonide (1)
- Flurbiprofen (1)
- Fusidic acid (1)
- Ganciclovir (1)
- Gentamicin (1)
- Ketotifen (1)
- Latanoprost (1)
- Latanoprost + Timolol (1)
- Levobunolol (1)
- Levofloxacin (1)
- Lidocaine (1)
- Liquid paraffin (1)
- Macrogol 3350 (1)
- Mercaptamine (1)
- Mitomycin (2)
- Moxifloxacin (1)
- Nedocromil (1)
- Ocriplasmin (1)
- Ofloxacin (1)
- Pegaptanib (1)
- Phenylephrine (1)
- Pilocarpine (1)
- Povidone (1)
- Proxymetacaine (1)
- Ranibizumab (1)
- Sirolimus (1)
- Sodium chloride (1)
- Sodium cromoglicate (1)
- Sodium hyaluronate (1)
- Tafluprost (1)
- Tetracaine (1)
- Timolol (1)
- Tobramycin (1)
- Triamcinolone acetonide (1)
- Varenicline (1)
- Yellow soft paraffin (1)
Planning (28)
- Biosimilars (4)
- New Medicines (17)
  - CCG commissioned new medicines (13)
  - NHS England commissioned new medicines (8)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (20)
Specialty (59)
- Allergy and immunology (2)
- Anaesthesia and pain (5)
- Cancers (7)
- Cardiovascular system disorders (4)
- Ear, nose and throat disorders (11)
- Endocrine system disorders (2)
- Eyes and vision (59)
- Gastrointestinal disorders (5)
- Haematological disorders (3)
- Infection and infectious diseases (13)
- Mental health and illness (1)
- Musculo-skeletal disorders (7)
- Nutritional and metabolic disorders (3)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (1)
- Respiratory disorders (6)
- Skin disorders (11)

Shortage of acetazolamide 250mg prolonged-release capsules (Advanz/Teva)

9 April 2020This memo advises on alternative treatment options during the shortage of acetazolamide prolonged release capsules.

Guidance on In Use Shelf Life for Eye Drops and Ointments

16 December 2019This document takes a risk based approach to assigning the in- use shelf life for eye drops used in UK hospitals based on the risks…

Shortage of Mitomycin-C Kyowa (all strengths)

7 November 2019UKMi with input from the Royal College of Ophthalmology and the National Clinical Director for Cancer at NHS England and Improvement, has drafted clinical advice…